AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 276: E553-E557, 1999;
0193-1849/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mamotte, C. D. S.
Right arrow Articles by Taylor, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mamotte, C. D. S.
Right arrow Articles by Taylor, R. R.
Vol. 276, Issue 3, E553-E557, March 1999

Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes

Cyril D. S. Mamotte1, Marian Sturm2, Jock I. Foo2, Frank M. van Bockxmeer1, and Roger R. Taylor2

1 Department of Biochemistry and 2 Department of Cardiology and Medicine, Royal Perth Hospital, Perth, Western Australia 6001, Australia

Compared with apolipoprotein E3 (apoE3), apoE2 is less effective in mediating the binding of lipoproteins to the low-density lipoprotein (LDL) receptor. The influence of the E4 isoform, which is associated with adverse effects on plasma lipids and coronary heart disease, is less clear. We compared the ability of very low density lipoprotein (VLDL) and LDL from paired E4/4 and E3/3 subjects to compete against 125I-labeled LDL for binding with the LDL receptor on cultured fibroblasts and Hep G2 cells. The concentrations of VLDL or LDL required to inhibit binding of 125I-LDL by 50% (IC50, µg apoB/ml) were determined, and results were assessed in terms of an IC50 ratio, E4/4 IC50 relative to E3/3 IC50, to reduce the influence of interassay variability. In Hep G2 cells, E4/4 VLDL was more effective than E3/3 VLDL in competing for the LDL receptor, the IC50 ratio being lower than unity (0.73 ± 0.31, P < 0.05, two-tailed t-test). IC50 values themselves were marginally lower in E4/4 than E3/3 subjects (3.7 ± 1.3 vs. 6.1 ± 3.7, P < 0.08). However, there was no difference between E4/4 and E3/3 VLDL in competing for the LDL receptor on fibroblasts or between E4/4 and E3/3 LDL in competing for the LDL receptor on either cell type. These results suggest that inheritance of apoE4 is associated with an increased affinity of VLDL particles for LDL receptors on hepatocytes and may partly explain the influence of the E4 isoform on lipid metabolism.

apolipoprotein E genotype; fibroblasts; Hep G2 cells


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. J. Havel and R. L. Hamilton
Hepatic Catabolism of Remnant Lipoproteins: Where the Action Is
Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 213 - 215.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. G. Parhofer, P. H. R. Barrett, T. Demant, and P. Schwandt
Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein B
J. Lipid Res., October 1, 2000; 41(10): 1596 - 1603.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online